Teva Sued by Hedge Funds for Delaying Disclosure of DOJ Price-Fixing Subpoena

Drug Industry Daily
A A
Hedge fund investors are suing generics manufacturer Teva for not being forthcoming about a federal price-fixing investigation — saying the company’s false statements before the eventual reveal of a subpoena resulted in losses of billions in shareholder value.

To View This Article:

Login

Subscribe To Drug Industry Daily